Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease.

Mediators of inflammation - 1 Jan 2023

Samah Nazirah, Ugusman Azizah, Hamid Adila A, Sulaiman Nadiah, Aminuddin Amilia

Abstract excerpt

Coronary artery disease (CAD) is a caused by atherosclerotic plaque buildup in the coronary arteries that supply blood and oxygen to the heart. Matrix metalloproteinase (MMP) is a family of zinc-dependent endopeptidase that is involved in various stages of atherosclerosis as demonstrated in in vitro and in vivo studies. MMP-2 is associated with both stable and unstable atherosclerotic plaque formation. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Matrix Metalloproteinase 2
Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Matrix Metalloproteinase 3

Share to Plaque, Atherosclerotic

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 37457745
DOI: 10.1155/2023/9715114
PMCID: PMC10348858

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease.PMID 37457745Read ↗

Matrix metalloproteinases in coronary artery disease.Semantic proximity Read ↗

The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis.Semantic proximity Read ↗

Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.Semantic proximity Read ↗

Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.Semantic proximity Read ↗

Status of biomarkers for the identification of stable or vulnerable plaques in atherosclerosis.Semantic proximity Read ↗

Genetic polymorphism of matrix metalloproteinase-1 and coronary artery disease susceptibility: a case-control study in a Han Chinese population.Semantic proximity Read ↗

MiRNA-34a, miRNA-145, and miRNA-222 Expression, Matrix Metalloproteinases, TNF-α and VEGF in Patients with Different Phenotypes of Coronary Artery Disease.Semantic proximity Read ↗

MiRNA-34a, miRNA-145, and miRNA-222 Expression, Matrix Metalloproteinases, TNF-a and VEGF in Patients with Different Phenotypes of Coronary Artery DiseaseSemantic proximity Read ↗

Matrix metalloproteinases in atherothrombosis.Semantic proximity Read ↗

Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.Semantic proximity Read ↗

Matrix metalloproteinases: a therapeutic target in cardiovascular disease.Semantic proximity Read ↗

Altered Vascular Extracellular Matrix in the Pathogenesis of Atherosclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.